Accretion Nutraveda IPO – Nutraceuticals and Wellness Sector Public Offering
Accretion Nutraveda Ltd has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an upcoming IPO aimed at strengthening its position in the nutraceuticals and wellness product market. The issue is structured to support expanded manufacturing capacity and working capital requirements. Investors tracking current IPO activity can review key details such as issue size, price band, business model, financial performance, and strategic growth outlook as the company prepares for market debut with a focus on high-demand health and nutrition segments.